CYP3A deficiency alters bile acid homeostasis and leads to changes in hepatic susceptibility in ratsXuan Qin, Xin Wang, Shengbo Huang et al.|Toxicology and Applied Pharmacology|2021Cited by 15
Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a GeneJie Liu, Xin Wang, Shengbo Huang et al.|Molecular Pharmacology|2021Cited by 14
P-glycoprotein mediates the pharmacokinetic interaction of olanzapine with fluoxetine in ratsYuan Xu, Xin Wang, Bingyi Yao et al.|Toxicology and Applied Pharmacology|2021Cited by 9
Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in ratsYuan Xu, Xin Wang, Shengbo Huang et al.|Toxicology Letters|2022Cited by 9
Construction of Humanized CYP1A2 Rats Using CRISPR/CRISPR-Associated Protein 9 to Promote Drug Metabolism and Pharmacokinetic ResearchJie Liu, Xin Wang, Shengbo Huang et al.|Drug Metabolism and Disposition|2023Cited by 7